Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.

Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.

Mary holds the appointment of Senior Executive in Residence and lead for the Partnerships and Innovation Division at the British Columbia Ministry of Health. This exciting new role is focused on health innovation and aligns with Mary’s long-standing commitment to system transformation.

Mary has had an impact on the health sector in British Columbia for close to 20 years. Most recently, she was the President and CEO of Vancouver Coastal Health (VCH) from 2014-2020. Mary joined VCH in 2007 as a Chief Operating Officer and prior to that she served on the Fraser Health Authority’s leadership team for seven years.

Throughout her career with the Health Authorities, Mary has pursued her passion for transforming the way care is delivered in order to ensure BC has a high quality healthcare system that is sustainable in the face of growing demand and constrained resources. This focus includes her leadership of the OneVCH employee engagement initiative that is committed to empowering and engaging staff and physicians across VCH. In 2019, Glassdoor, one of the world’s largest employee recruitment sites, named Mary as one of Canada’s top 25 CEOs based on employee reviews.

As CEO of VCH, she encouraged a focus on innovation and discoveries that improve patient health, transform health systems, and directly impact health and economic outcomes. Her longstanding interest in virtual care enabled health providers to continue delivering care to patients and clients across VCH during the recent weeks of the COVID-19 pandemic.

Mary is a graduate of the Harvard Business School’s Master of Business Administration program and the West Virginia University’s Industrial Engineering program.

With more than 20 years of international experience in both the academic and private sectors, Dr. Catalina Lopez-Correa’s deep understanding of genomics and innovation has inspired leaders in science and industry to collaborate toward solving some of the world’s greatest challenges.

Dr. Lopez-Correa is the Executive Director of the Canadian COVID Genomics Network (CanCOGeN) at Genome Canada, where she is leading a pan Canadian collaborative effort to sequence viral and human genomes to help inform public health and policy decision. Before joining Genome Canada, Dr. Lopez Correa was Chief Operating Officer at Ruta N Medellin. In this capacity, she led the operations of a world class innovation hub that uses cutting edge technologies to solve the city’s most pressing social and economic challenges. Prior to Ruta N, Dr. Lopez-Correa was the CSO and Vice-President Sectors at Genome British Columbia (2016-2019) and CSO and Vice-president Scientific Affairs at Genome Quebec (2008-2015), where she was instrumental in developing competitive teams for national and provincial research and innovation initiatives raising the profile of Canadian genomics on the global stage.

Before becoming one of Canada’s leading advocates for genomics research and translation, and an international leader in using innovation to solve world challenges, Dr. Lopez-Correa held senior research positions with pharmaceutical giant Eli Lilly and the renowned deCODE genetics lab in Iceland. As part of her commitment to international development, Dr. Lopez-Correa has championed several initiatives aimed at demonstrating the impact of genomics and innovation in developing countries, including a book on Genomics in Emerging Economies, white paper with the World Economic Forum and several articles. Since 2002 she has served as evaluator for large multinational projects funded by the European Commission and has been recognized with several awards nationally and internationally.

Dr. Lopez-Correa holds a Medical degree from the UPB in Colombia, a Master’s degree in Human Genetics from Paris V University in France, a PhD in Medical Sciences from the KULeuven in Belgium, and a mini MBA from McGill University in Canada.

Awards:
In 2017 she received the Canadian Senate 150th Anniversary Medal. In 2013 she was recognized by National Order of Merit Award in the Rank of Officer, appointed by the Honorable President of the Republic of Colombia. This honorable distinction is conferred to Dr. Lopez-Correa for her outstanding professional and academic career and the scientific contributions in the field of Genomics in Canada. In 2012 she was recognized as one of the 100 Colombians living abroad that have been highly successful on their professional career.

Shelagh Maloney has held a number of senior positions since joining Infoway. She manages relationships with patients, clinicians and the federal government, and leads performance analytics and communications and marketing.

She has held a number of executive positions in the public and private sectors, where she honed her relationship management and business development skills.

Shelagh holds a B.Sc. in Applied Health Sciences from the University of Waterloo and is a Certified Professional in Health Information & Management Systems (CPHIMS-CA).

In 2017, she received the inaugural Women Leaders in Digital Health Award, which recognizes female visionaries who are harnessing the power of IT to transform health and health care in Canada.

Dr. Verna Yiu joined Alberta Health Services (AHS) in August 2012 as Vice President, Quality and Chief Medical Officer. In this role, she oversaw the integration and co-ordination of a health delivery model for the province and was accountable for Quality & Healthcare Improvement, Strategic Clinical Networks, Clinical Informatics and Clinical Information Systems, Medical Affairs, and partnerships with academic institutions and other physician-led organizations.

The principal focus of her initial role within AHS was quality and patient safety, engagement, leadership development and fostering relationships between medical staff and the health care system.

Prior to joining AHS, Dr. Yiu served as interim Dean of the Faculty of Medicine and Dentistry at the University of Alberta preceded by senior positions in the dean’s office from 2000.

She is a graduate of the University of Alberta (U of A) and Harvard University, and is currently a Professor of Pediatrics at the University of Alberta. She has also led various areas of health administration for more than 18 years, both within the health care delivery system and in academic settings.

Since returning to the U of A in 1994 as a pediatric nephrologist, a clinical role she continues to have today, her leadership roles have spanned heading clinical operations, leading medical education reforms and developing strong partnerships with academic institutions, government bodies and other clinician-led organizations.

Dr. Yiu was appointed interim President and CEO of Alberta Health Services by the AHS Board effective January 11, 2016 and became the permanent President/CEO June 3rd, 2016. Since being appointed in this role, Dr. Yiu has led the organization in the development of a new vision, refreshed values, and a health and business plan focused on the quadruple aim based on 4 foundational strategies (patient first, people, research/innovation/analytics, and IMIT strategies).

Bogi Eliasen is Director of Health at the Copenhagen Institute for Futures Studies (CIFS). He comes from the Faroe Islands and is educated in Political Science from the University of Aarhus, Denmark. He has been employed in the Faroe Business Affairs and Ministry of Foreign Affairs and worked as a consultant over the last 20 years for politicians, the public sector and private companies.

Bogi is one of the initiators of the ambitious genome project FarGen which aims to sequence the genomes of the whole population of the Faroe Islands. As CIFS health expert Bogi sets the future stage of genomics, data and health framed with the holistic vision of shaping the future personalized health paradigm as a part of ambitious projects and networks around the world.

He calls himself a knowledge broker whose expertise lies in combining various fields of knowledge.

Dr. Kendall Ho’s academic and research interests fall into the domain of technology-enabled knowledge translation (TEKT) – the use of information technologies to accelerate the incorporation of the latest health evidence into routine practice. Specific directions within TEKT include telehealth, information and communication technologies (ICT) and patient safety, ICT and public engagement, and evidence-based policy translation in eHealth.

Dr. Belanger is the Vice President, Quality and Chief Medical Officer for Alberta Health Services (AHS) and member of the Executive Leadership Team. His current role is to help oversee the integration and coordination of a complex health delivery model for the province through six accountability functions: Medical Affairs and office of the Chief Medical Officer, Quality and Healthcare Improvement, Patient Relations and Patient Engagement, Connect Care, Clinical Informatics, Strategic Clinical Networks, while maintaining effective partnerships with academic institutions and other physician led organizations.

Previously, Dr. Belanger also oversaw CancerControl Alberta which included 17 Cancer Centres (two tertiary centres in Edmonton and Calgary, four regional centres in Grande Prairie, Red Deer, Lethbridge and Medicine Hat and 11 community centres. Patient Services for Cancer Control included: radiation therapy, systemic therapy, blood and bone marrow transplant, clinical trials, patient navigation and supportive care.

A key mandate of the Quality and CMO position is to maintain a strong emphasis on the importance of quality and patient safety, engagement, leadership development and relationships between the medical staff and the health care system.

Prior to assuming this role, Dr. Belanger was the Interim Vice President Quality and Chief Medical Officer AHS, Vice President and Medical Director Central and Southern Alberta AHS, and the Medical Director Calgary Zone AHS. He has also held several medical leadership positions in AHS and the former Calgary Health Region. These include Senior Vice-President and Zone Medical Director for the Calgary Zone (AHS); Acting Executive Vice-President and Chief Medical Officer of AHS; Zone Medical Director, Calgary Zone, (AHS); and the Calgary Health Region/University of Calgary interim and deputy department head of Pediatrics. He continues to practice as a Pediatric Emergency Physician at the Alberta Children’s Hospital and South Health Campus in Calgary.

Originally from Ottawa, Dr. Belanger obtained his medical degree from the University of Ottawa. His post-graduate work in Pediatrics was done at the University of Alberta and McGill University. He completed his fellowship in Pediatric Emergency Medicine at McGill University. Dr. Belanger continues to be active in resident education, maintaining his status as a Clinical Associate Professor in the Department of Pediatrics at the University of Calgary.

Dr. Belanger has assumed active roles in national organizations. He was the President of the Canadian Association of Emergency Physicians (CAEP) from 2002-04 and chaired the Specialty Committee, Paediatric Emergency Medicine, Royal College of Physicians and Surgeons of Canada from 2006 to 2012.

Dr. Belanger is a patient-focused senior health executive who is recognized for his commitment in building quality and safety cultures, and realizing whole system performance and transformation. He is a collaborator-builder noted for his “bottom up” approach, and developing strong ties with clinicians, academic medicine, and other community stakeholders for meeting patient needs, and accomplishing high level organizational goals. He is an enthusiastic strategic and operational medical leader who moves teams towards implementing creative solutions and attaining greater system functioning and patient outcomes.

Dr. Belanger lives in Calgary, Alberta. He is an avid cyclist and likes to travel and spend time with his family.

Dr. Jonathan Choy is the Provincial Medical Director for Virtual Health, Alberta Health Services, and is promoting the concept of delivering “High quality healthcare, anytime, anywhere” to all Albertans. His team facilitates the integration of virtual services into clinical programs within the organization, and collaborates with different Strategic Clinical Networks as well as stakeholders in Alberta Health in exploring new care delivery models. In addition, he is involved with the College of Physicians and Surgeons of Alberta in developing practice advice for virtual care delivery, and was a working group member for the Canadian Medical Association Task force on Virtual Care in 2020.

He practices as a clinical cardiologist at the Mazankowski Alberta Heart Institute, and also erves as the Associate Dean for Clinical Faculty at the University of Alberta.

Megan Hunt is the Executive Director of Primary Care & eHealth. Megan resides in northern BC in the Carrier and Sekani territory. She began her journey with the First Nations Health Authority in 2014 as the Project Director of eHealth, leading the First Nations Telehealth Expansion Project and team. Following this Megan became the Director of eHealth to support the ongoing implementation and transformation of Action Item 23 of the Transformative Change Accord: First Nations Health Plan to create a fully integrated clinical telehealth network. A project of this magnitude was unique and required strategic thought leadership and change management to solution multiple moving project activities and deliverables along with community, regional and provincial partners. An important task coming into this role was to recruit and build the human resource capacity within the project and organization to deliver on Action Item 23 and further develop digital health and wellness opportunities to support First Nations adoption of technology to access equitable, quality, culturally safe and timely health and wellness programs and services in community.

In 2016, she had the honor of working as the Regional Director for the Northern Region to cover a one-year maternity leave. This position provided her with an opportunity to utilize her leadership experience in health and child and family services within Northern Indigenous communities and organizations in a very integrated manner. Megan had the opportunity to provide high level direction and oversight with the northern regional team and 54 First Nation communities, First Nations Health Service Organizations, the regional health authority, community Health Leads and their Elected leadership. Additionally, she was responsible for the development of a strategic operational plan, leading change and managing transitions, leading the motivation and development of direct reporting staff and overall northern team.

Great learning and knowledge was developed with a broader understanding of the importance of regionalization through the delivery of Regional Caucus and Sub-regional sessions; Northern Regional Table and the Northern First Nations Partnership Table. Additionally, she further recognized and appreciated the important interplay and role that our Vancouver home office and associated programs and departments have in helping to achieve healthy and vibrant First Nations children, families and communities. This knowledge was also advanced through having accountability for the overall FNHA community engagement functions including communication and planning with all health system partners, tables, committees and Nations while ensuring regional input was inserted into all senior levels of the FNHA. The experience in working regionally was incredibly rewarding and she was very proud to be a part of the development, innovation and implementation of JPB projects in northern communities such as: Phase 1 Mobile Support Teams (MST), Coastal Primary Care Initiative, Men’s Wellness programs, Crisis Response development, Northern Jordan’s Principal, Northern Respecting Tobacco Strategy, Traditional wellness and Land Based Healing, Integrated Primary Care within Mobile Support Teams, Home Care Assistant Program and other regional and community driven initiatives, conferences and training aligned with the northern region health and wellness plan and associated regional and provincial funding envelopes.

Most recently Megan has held the role of Director of Primary Care and eHealth with responsibility for the strategic leadership and direction to operationalize fully aligned and integrated primary health care and eHealth, including Joint Project Board (JPB), First Nations Led Primary Care Initiatives and the First Nations Virtual Doctor of the Day and the First Nations Virtual Substance Use and Psychiatry program to advance First Nations health and wellness in BC. Having the opportunity to be a part of setting the direction, coordination, facilitation and sustainability of fully integrated primary health care services within the regions, enabled by eHealth programs and services has resulted in baring witness to and being a part of further achieving Indigenous health equity across the province.

In this role, she has provided strategic support in the ongoing development of the FNHA Primary Care ++ model of health services and the important role that building inter-professional team based care plays in the delivery of quality indigenous health services.

Dr Kingsford is Provincial Chief Medical Information Officer at Ministry of Health in the province of British Columbia, Canada. He is a family physician with an Electronic Engineering PhD in artificial intelligence, with particular interests in artificial intelligence, machine learning, interoperability, integrated care and workflow coordination. He is a core member of the leadership team advancing the provincial Digital Health Initiative from both clinical and ecosystem architecture perspectives, and is vice-chair of the provincial Clinical Leadership Committee for digital health.

Ted Patterson is the Assistant Deputy Minister (ADM) of the Primary Care Division at the Ministry of Health. Prior to this appointment, Ted led a number of ADM portfolios in the Ministry, including Primary and Community Care Policy, as well as Health Sector Workforce. Previously, Ted was Executive Director at the Public Sector Employers’ Council (PSEC) Secretariat in the Ministry of Finance where he was responsible for collective bargaining and compensation strategies for the Health, K-12 and University sectors. In this role, Ted also served as a member of the Board of Directors for the BC Public School Employers’ Association and represented government at a number of major negotiation tables. Ted holds a Bachelor of Arts and a Master of Arts in Political Studies, both from the University of Saskatchewan.

Dr. John Pawlovich is a Clinical Professor in the Department of Family Practice at University of British Columbia (UBC). He completed his medical degree in 1994 at UBC. He then went to Chilliwack, BC where he completed a two year Family Practice Residency. He has worked in many rural and remote sites across Canada. Over the last twenty five plus years an interest in Indigenous Health evolved with a focus of bringing innovative primary care and specialty services onto reserve to reach the people most in need. Using new technology such as telehealth from his home office in Abbotsford, British Columbia, Dr Pawlovich is able to connect to multiple remote Indigenous communities to help provide the daily primary care they deserve and need. He continues to make monthly visits to northern Indigenous communities to ensure the closeness of his relationship to the people remains strong. He is currently the director of the Rural Education Action Plan in British Columbia, the Medical Director for Carrier Sekani Family Services and the Telehealth Sector Lead for the Rural Coordination Center of BC. Dr Pawlovich is involved in many telehealth initiatives in the province of British Columbia. He is a co-founder and co-lead of the BC Virtual Health Grand Rounds, and the e-Health theme lead for the UBC Faculty of Medicine. He speaks both nationally and internationally on virtual healthcare solutions and systems.

Troy is an industry strategist and technology executive with over 20 years’ experience in healthcare, retail, and manufacturing industries. He specializes in accelerating digital transformation and guiding enterprise organizations on creating and implementing technology roadmaps.

Currently, Troy leads Cisco’s Public Sector Healthcare practice globally where he advises healthcare systems, enterprises and governments on how patient and clinician experience is rapidly evolving through applied technology. Additionally, Troy serves as a board member for a healthcare provider and separately as an early-stage startup champion. Prior to joining Cisco, Troy held leadership roles in management consulting firms specializing in healthcare technology with experience across all stages of the continuum of care for Enterprise healthcare systems. He began his healthcare technology career by learning on the front lines with doctors and nurses about how to digitize clinical workflows while implementing EHR’s in large hospitals across North America.

Before dedicating his career to healthcare technology, Troy spent over 10 years developing international supply chain models and streamlining complex manufacturing of consumer products across several continents. Additionally, he held leadership roles in international product development, partner management, global sourcing, and international sales teams across North America, EMEA, and Asia.

Troy holds an MBA in Strategy and Finance from Vanderbilt University and graduated from Michigan State University with dual degrees including a BA in Advertising and a BS in Engineering, Packaging. He currently lives in one of the healthcare capitals of the USA, Nashville, TN.

Dr. Shez Partovi obtained his medical degree from the prestigious McGill University, in Montreal, Canada and completed his neuroradiology subspecialty training at Barrow Neurological Institute in Phoenix, AZ.

He is a serial entrepreneur and has launched several health IT companies, one of which was a telehealth company built on AWS. After a decade of clinical practice, Dr. Partovi transitioned into executive roles at Dignity Health where he served as its Chief Health Information Officer and, subsequently, as Chief Digital Officer/SVP of Digital Transformation. As the CHIO, Dr. Partovi oversaw the deployment of Cerner across the enterprise in both inpatient, outpatient and oncology settings. As the CDO, Dr. Partovi was responsible for the digital experience of consumers, patients and providers across Dignity Health.

Shez joined Amazon Web Services in 2018 as the Worldwide lead for Healthcare, Life Sciences and Genomics. He is currently working on over a dozen large scale initiatives across the globe and has a unique perspective of the opportunities to transform healthcare worldwide. Dr. Partovi combines his clinical, entrepreneurial and AWS experience to help the audience Think Big and imagine the Art of the Possible.

Howard Waldner is the past President and Chief Executive Officer of Vancouver Island Health Authority, serving in this role from 2004 until 2013. He is curently CEO of Caledonia Solutions, a strategic consulting company he founded in 2013.

He is a visionary and innovative leader with over 30 years of experience of managing health sysytems in both Canada and the U.K. He has a keen interest in system innovation, transformation and performance improvement. He is also passionate in the area of health facility planning, design and procurement and has led the development of number of large and successful hospital projects using both traditional and alternate funding approaches. He received the Canadian College of Health Leaders National Award for Innovation in Health in 2013.

He is a certified member of the Institute of Corporate Directors, and currently serves as an Independent Board Director of Strata-Health Solutions, a successful Calgary based Health IT company, and is a partner with Prioritize Software, a Vancouver based strategic solutions company. He also serves as a volunteer member of the Telus (Victoria) Community Board and has served on a number of “non-profit” Boards, including the Canadian Institute for Health Information, the BC Academic Health Council, (which he chaired for 5 years), the United Way Campaign Cabinet, Carewest, VRRI, and the Greater Victoria Coalition to end Homelessness.

Prior to joining VIHA in 2004, he was the Deputy Chief Executive and Executive Vice President and Chief Operating Officer for the former Calgary Health Region from 1999 until 2004. Before moving to Calgary in 1999, he held a number of senior leadership roles within the Scottish National Health Service, most recently as the Chief Executive of Dundee University Teaching Hospitals NHS Trust.

He received his Executive MBA from the University of Glasgow, Scotland, and is a Certified member of the Canadian College of Health Leaders and a Fellow of the United Kingdom Institute of Health Care Managers.

He is Adjunct Professor in the Faculty of Medicine of the University of British Columbia, and teaches on a number of executive leadership and masters programs in the School of Public and Population Health.

Dr. Caron is a member of the Sagamok Anishnawbek First Nation. She is a practising surgical oncologist in northern British Columbia (BC) where she provides cancer screening, diagnosis and surgical care for individuals in rural, remote, and northern BC – a large percentage of whom are Indigenous.

Dr. Caron is the sole Indigenous physician within BC Cancer, the only Indigenous scholar within the University of BC’s (UBC) Faculty of Medicine, an Associate Professor at UBC Northern Medical Program as well as a Senior Scientist at Canada’s Michael Smith Genome Sciences Centre at BC Cancer.

Dr. Caron is the inaugural First Nations Health Authority Chair in Cancer and Wellness. She is also a founding co-Director of the UBC Centre for Excellence in Indigenous Health (CEIH) and Consultant in development of BC’s first-ever Indigenous Cancer Strategy to improve Indigenous cancer outcomes and experiences in BC. “Improving Indigenous Cancer Journeys: A Road Map”.

Dr. David Huntsman is a Professor of the Departments of Pathology and Laboratory Medicine and Obstetrics and Gynaecology at UBC, the Dr. Chew Wei Memorial Professor of Gynaecologic Oncology and is the Canada Research Chair in Molecular and Genomic Pathology. Dr. Huntsman directs OVCARE, BC’s multidisciplinary ovarian cancer research team and conducts his research at the BC Cancer Agency and the Vancouver General Hospital.

In addtion to providing most of the data that underpins the management of hereditary gastric cancer, Dr. Huntsman’s research has led to development of predictive and prognostic tissue based cancer biomarkers for ovarian cancer and a wide variety of other tumour types. His team created a blueprint for subtype specific ovarian cancer control and have been leaders in the application of novel genomic technologies to better prevent, diagnose and treat ovarian cancer. Specifically, next generation sequencing was used to discover the key driver mutations in granulosa cell and sertoli leydig cell tumours as well as clear cell, endometrioid and small cell carcinomas. These discoveries are being translated into improved diagnostics and treatment strategies. Based on research into precurosr lesions the OVCARE team has implemented a population based prevention strategy for ovarian cancer that includes opportunistic salpingectomy and more pervasive genetic screening. Huntsman’s most recent research has focused on the cellular origins of clear cell and endometrioid ovarian carcinomas the role of somatic mutations in the development of endometriosis and the transformation of endometriosis into these cancers.

Collaboration and entrepreneurship are both critical ingredients of clinically relevant research. To that end Dr. Huntsman leads several Canadian and international collaborative networks and recently founded a company, Contextual Genomics, to increase the clinical and economic impact of his work.

Dr. Gary Pansegrau, is the Senior Executive Director Clinical Programs and Policy at BC Cancer accountable for the operations, resources and performance management all of the Provincial Clinical Programs and Tumour Groups and provides provincial leadership and direction in establishing organizational strategy and policy. He is a Medical Oncologist specializing in breast cancer and has been with BC Cancer since 2004 after completing his medical school training in Toronto, and his internal medicine and medical oncology training at UBC. He has held several leadership roles throughout his career including Executive Medical Director at Vancouver Centre, and prior to relocating his clinical practice to Vancouver in the fall of 2018, he was the first Regional Medical Director at BC Cancer Surrey Centre. He was also the Chair of the Priority and Evaluation Committee (PEC) for BC Cancer from 2013 – 2020.

Dr. Regier is a Senior Scientist within Cancer Control Research, BC Cancer, and an Associate Professor at the School of Population and Public Health, Faculty of Medicine, University of British Columbia. Over the past 15 years, Dr. Regier’s research has focused on the economics of access to precision medicine, particularly in context to generating and using real world evidence to support sustainable regulatory and learning healthcare systems. He has presented his work internationally, with invitations from the US National Academies of Sciences and the World Economic Forum. He is Deputy Editor at the International Journal of Technology Assessment in Health Care and currently serves on BC’s Drug Benefit Council, which makes evidence-informed recommendations to the Ministry of Health about the listing of drugs on the PharmaCare program formulary.

Sue is the CEO of Canada’s Digital Technology Supercluster – driving the development of digital technology platforms and products that will transform businesses and industries while making Canada a world leader in digital technology. The Digital Technology Supercluster brings together organizations of all sizes, from industry, academia, the private and the public sector, to work together on solving some of the most significant economic and social issues through the development and implementation of world leading digital technologies. The Supercluster is leveraging Canada’s expertise in data analytics, genomics, quantum computing, mixed and augmented reality, the Internet of Things and AR and VR to deliver technologies in data commons, digital twins and all aspects of precision health while creating jobs and growing Canada’s international competitiveness. Over 300 organizations are working with the Supercluster from diverse sectors including manufacturing, mining, healthcare, agriculture, research, forestry, aviation, software development, telecom and more.

Prior to joining the Supercluster Sue was the Managing Partner of one of Canada’s leading law firms, the CEO of Canada’s largest chain of independent retail pharmacies and most recently the CEO of Canada’s largest diagnostic lab. In each of these roles Sue mobilized diverse teams to drive business growth, implement large-scale organizational change and develop and implement transformational technologies.

Sue and her husband Brad are the proud parents of three daughters and when not transforming organizations, Sue and her family can be found in remote areas of BC’s wilderness, exploring all that BC has to offer. Sue has been recognized for community and business leadership with awards including: Honorary Doctorate of Technology (BCIT), UBC Faculty of Law Distinguished Alumni Award, University of Victoria Distinguished Entrepreneur, YWCA Woman of Distinction, Queen’s Counsel, Hall of Fame for Canada’s Top 100 Most Powerful Women, and the Influential Women in Business Lifetime Achievement Award.

Fiona Dalton became President and Chief Executive Officer of Providence Health Care on April 23, 2018.

Ms. Dalton brings over 23 years of health care experience to Providence. Prior to joining Providence, she was the CEO of University Hospital Southampton NHS (National Health Service) Foundation Trust in the United Kingdom. This renowned academic health sciences centre has 10,000 employees and an annual budget of over $1.2 billion Cdn.

Ms. Dalton’s accomplishments have included:

• developing and launching a new values-based organizational vision;
• being nationally recognized for improving quality and safety;
• improving hospital performance and patient outcomes;
• enhancing research performance;
• leading successful staff health and well-being strategies;
• focusing on quality improvement, innovation and digital services; and
• delivering a successful capital program, improving and expanding facilities for patient care, research and education, with academic, commercial and charitable partners.

She holds a BA Honours in Human Sciences from Queen’s College, Oxford University. She received an Honorary Degree of Doctor of Science by the University of Southampton in 2017.

She has previously served as the Chief Operating Officer and Interim CEO of the Great Ormond Street Hospital NHS Foundation Trust; Executive Director of Strategy and Business Development at Southampton University Hospitals NHS Trust; and Divisional Director, Responsible for Surgery, Cancer, Critical Care, Neurosciences, Theatres & Anaesthetics, at Oxford Radcliffe Hospitals NHS Trust.

Dr. Federica Di Palma holds a PhD in Immunogenetics from the University of Reading and brings over 15 years of experience in genomics and data science, with strong international connections in the US through institutions such as NIH, Harvard, and MIT. Most recently she was Director of Science at the Earlham Institute in the United Kingdom where she led the Institute BBSRC core strategic programme in food security, as well as a wide variety of research programmes aimed at delivering the cross-disciplinary application of novel computational and molecular biology technologies to the understanding of living systems.

She is passionate about exploring and preserving Biodiversity around the world. She leads numerous multidisciplinary international research programs for Development Assistance Committee countries aimed at generating strategic partnerships, building human and infrastructure capacity, and translating scientific knowledge into policy and private sector engagement to deliver long-term impact. She remains Professorial Fellow in Biodiversity in the School of Biological Sciences at the University of East Anglia.

Dr. Di Palma’s previous experience also includes her roles as the Assistant Director, Vertebrate Genome Biology at the Broad Institute of Harvard, a Senior Research Scientist and Service Centre Manager at the Hubbard Centre for Genome Studies at the University of New Hampshire, Durham, and a Fogarty Fellow, National Institutes of Health.

“I believe that multidisciplinary research, partnerships, and multisectoral perspectives are key to solving today’s health and environmental challenges and effectively informing policy development and implementation. The acquisition and analysis of large amounts of genomic data have become a common practice and it is key to drive innovation. The efficient analysis of such data through bioinformatics and artificial intelligence has unprecedented potential to transform how we respond to these major challenges faced by humanity.”

Dr. Alexandra T. Greenhill is one of Canada’s leading physicians in digital health innovation and the cofounder CEO and Chief Medical Officer of Careteam Technologies, the digital health platform solving the fragmentation of healthcare that was the recipient of the Canadian Medical Associations’ Joule Innovation Award.

After having implemented health innovation at scale and practiced medicine in Quebec, Ontario and BC, she now leads and advises Canada’s most promising technology companies. Dr. Greenhill’s work has received many recognitions, including Startup Canada’s Woman Entrepreneur of the Year Award, YWCA Woman of Distinction – Entrepreneurship, WXN’s Top 100 Most Powerful Women in Canada, BIV Top 40 under 40 and the Queen Elizabeth II Diamond Jubilee Medal of Service.

Deepak Kaura, MD, FRCPC, MBA – Deepak is 1QBit’s Chief Medical Officer and the Chair of the Board of Joule, a Canadian Medical Association subsidiary. Prior to these appointments, Deepak spent 5 years in Qatar with the Sidra Medical and Research Center, most recently as the Executive Chairman of the Foundational Clinical Services Management Group, where he helped to set new standards inpatient care for women and children and led ground-breaking work in the application of machine learning to healthcare. Deepak has also served the Royal College of Physicians and Surgeons of Canada as a Subspecialty Chair in Pediatric Radiology and has established a number of startups in the healthcare space. He has received his MBA from HEC Paris, FRCPC following training in Calgary, and his MD from the University of Manitoba. He has held faculty appointments as Associate Professor at Cornell University and the University of Calgary.

Nancy White is the CEO of Inagene Diagnostics Inc. Prior to joining Inagene, she held a variety of executive roles within the pharmaceutical industry, encompassing both commercialization and operations. She has worked the healthcare, biotechnology, and government sectors and is known for exceeding expectations in domestic and international markets. Her passion for personalized medicine stems from her experience in oncology and she is dedicated to bringing pharmacogenetics into mainstream healthcare.

Dr. Abrams is a Managing Director in Deloitte’s Strategy Practice and Deloitte’s Chief Medical Officer.

Ken is an anesthesiologist with over 30 years of experience as a practicing physician and physician executive in academic medical centers and integrated delivery systems. Dr. Abrams has market eminence as a physician leader and as a thought leader in clinical strategy, operations & performance improvement, virtual health, and clinical integration.

Prior to joining Deloitte, Ken worked at Northwell Health (formerly North Shore LIJ Health System), where he served as senior vice president of Clinical Operations, chief quality officer, and associate chief medical officer for the health system. He has led multiple projects including a surgical services redesign, anesthesia department turnaround, and the 2010 National Quality Forum (NQF) National Healthcare Quality Award.

Prior to working at the Northwell Health, Ken was the patient safety officer and chairman of Anesthesiology at AtlantiCare. His achievements in his five years there included the creation of the Patient Safety Committee, a clinical transformation patient flow project and the creation of a critical care strategic development group, and a senior leader in pursuing AtlantiCare’s Baldrige National Quality Recognition. Prior to AtlantiCare, Ken spent almost 13 years at Mount Sinai Medical Center in New York as associate professor of Anesthesiology and medical director for Perioperative Services, among other roles.

Ken holds a doctor of medicine (MD) degree from Sackler School of Medicine/Tel Aviv University, an MBA from Zicklin School of Business/Baruch College and a bachelor’s degree in biology from the University of Rhode Island.

Ken also played Division 1 soccer while at URI and had the honor of playing on the U.S. Maccabiah soccer team, winning a silver medal. He lives in Florida with his wife, Mercy, and enjoys boating, tennis, and the outdoors.

As a principal, and Chief Innovation Officer for Deloitte’s Health Care practice, Jen is a trusted advisor who enables health care system executives to embrace and prepare for disruptive innovation. Jen leads teams that enable healthcare market leaders to leverage applied innovation to define business growth strategies, design new models of clinical care, and future proof the business, with a shared agenda to improve customer connectivity, clinical outcomes, access, and provider satisfaction. Leading Deloitte’s Life Science’s & Healthcare Innovation Catalyst in New York, Tel Aviv, Silicon Valley, Jen leads team in the sensing/scanning of the healthcare ecosystem, collaborating with stakeholders to incubate & prototype new platforms & solutions across healthcare, health & wellness. She is a nationally acclaimed speaker on the topics of Future of Health & Future of Work.

As nextgen technologies, artificial intelligence, predictive analytics, supported by engagement platforms and new talent models are being adopted across the globe, the nature of work across industries is changing. Jen is passionate about partnering with healthcare organizations through the next wave of disruption, defining innovative business models, the organization & workforce strategies that enable them, and how together we can convene the ecosystem to create value on the journey to health and wellness. Jen leads teams across the US partnering with Healthcare organizations to navigate the rapidly changing ecosystem by designing strategies & new business models addressing the intersection of the Future of health & Future of Work infused with NextGen tech.

As co-founder and executive sponsor of Deloitte’s Physician Leadership Academy, it is Jen’s mission to support the evolving leadership capabilities of clinician leaders as the era of the emergence of the Clinical Healthcare CEO. Jen has published studies and papers at the intersection of the Future of Health and the Future of Work: Technology and the workforce of the future, The future of work, & Toward Systemness; led podcasts on Inclusion & Diversity as a strategic lever and the power of Leadership capabilities in Healthcare; She has presented at strategy summits, Exponential Medicine, Scottsdale Institute, AVIA Summit, NACHI, Modern Healthcare Future of Work summit,& been featured as a Modern Healthcare “Executive Spotlight”. Most recently, she is launching a study on the Innately (non-cognitive) Human Capabilities.

Jennifer received a Bachelor of Arts in Anthropology from Amherst College, as well as a Masters of Business Administration in Financial Management from Columbia Business School and a Masters of Public Health in Women’s and Children’s Health from Columbia School of Public Health. She was a Fellow, USC Center for Effective Organizations; International Women’s Forum Fellow.

A telecom executive with more than 25 years of leadership experience, Juggy has enjoyed a fulfilling and rewarding career with TELUS leading many emerging technology businesses and operations. She has a well-established reputation for building and leading high performing teams with some of the highest engagement scores and engagement transformations across the company. Juggy is known for her unrelenting focus on quality and efficiency combined with a genuine concern and commitment for all who work with her. Juggy has led ground-breaking service development initiatives and diverse portfolios, and gained invaluable experience in strategy, marketing and operations management at TELUS overseeing many different portfolios throughout her tenure.

Currently, as the Vice President of Consumer Health, Juggy is responsible for the national strategy, execution and operation of the Consumer Health business unit for TELUS Health. Juggy believes in empowering Canadians with the right tools, information and support so they can live happier and healthier lives. She is revolutionising access to healthcare in Canada with important products she has launched virtual care (Babylon by TELUS Health), curated health content in the TELUS Healthy Living Network, personal emergency response systems (largest Canadian-owned provider in Canada), personal health records and more. She was the executive producer for the critical documentary “PainKiller” on the opioid crisis ravaging our country.

TELUS Health transforms information into better health outcomes by ensuring valuable medical information is in the right hands at the right time. TELUS Health is also the largest healthcare IT company in Canada. TELUS is the leading provider of electronic medical records, pharmacy management software, remote patient monitoring and health benefits claims management in Canada.

Community leadership is a critical component of Juggy’s leadership story. Juggy is the Vice Chair for the VGH & UBC Hospital Foundation Board, she is a Director for the Vancouver International Airport Authority (YVR), the Canadian Chamber of Commerce, and the Canadian Men’s Health Foundation. She previously served as a director on the Justice Institute of British Columbia, the Vancouver Community Board, and the Vancouver Board of Trade’s Women’s Leadership Council. Juggy also serves as an advisor to the City of Vancouver on racial and social justice issues.

Juggy is the recipient of the Diversity Champion award at TELUS. This award recognises leaders who are champions of all diversity and celebrates those who leverage diversity of thought to help advance business strategy. Juggy received the Leadership Excellence Trailblazer Award by Canadian Women in Communications and Technology (WCT) as well as the Forty Under 40 award in BC by Business in Vancouver for her business achievements, inspirational leadership and community contributions. In 2019, Vancouver Magazine recognized her as one of the most powerful 50 people in BC.

Juggy holds an MBA from Queen’s University in Kingston, Ontario. She has also completed Executive Development programs at Harvard and INSEAD.

Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.

Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.

Dr. Helia Mohammadi is the National Healthcare Chief Data Scientist for Microsoft Canada and a thought leader in the research and healthcare industry. With over 14 years’ experience in research and applied AI, her work has leveraged and extended Machine Learning and Cloud solutions to deeply influence key domains including predictive analytics, genomics research, and precision medicine.

Helia completed a Doctorate in Electrical and Computer Engineering from the University of Toronto. She received her MSc degree in Computer Science from Ryerson University after simultaneously completing a BSc degree in Computer Engineering and a BBA in Business Administration. Her work resulted in peer-reviewed publications and patents.

As the National AI Ambassador for the Microsoft Canada AI Country plan and an observing board member of the Digital Technology Supercluster, Helia has been pivotal in spearheading Canadian Healthcare digital transformation and AI adoption strategy.

She has received numerous distinguishing awards and scholarships, including the “Best Graduate Thesis Award in Recognition of Excellence in Research and Nomination for Governor General’s Gold Medal” and made the list of the “Top 30 Influential Women Advancing AI in Canada”.

She strives to empower the healthcare and research community to positively affect quality of life for patients and medical professionals.

Dr. Robert Fraser is the President and CSO of Molecular You, a digital health company delivering molecular-level personalized health insights and action plans. Dr. Fraser has been at the forefront of developing the framework and technologies to bring personalized medicine into healthcare practice. He is the co-founder of The Personalized Medicine Initiative (PMI), GenXys Health Care Systems, Personalized Biomarkers Incorporated, Mesentech Corporation and Novobind. Dr. Fraser has led drug discovery and development projects at Sanofi, Xenon, Neuromed and CDRD and has been involved in raising of more than $37M in funding. He completed his Ph.D. in the molecular mechanisms of endocrinology at the University of Alberta and Harvard Medical School and Post-Doctoral Fellowships at Hospital for Sick Children, Toronto and IGBMC, Strasbourg France.

Bringing more than 35 years of experience in healthcare-related industries, Dianne currently serves as the Senior Vice President of the Government Division at Alberta Blue Cross. With a strong track record of establishing strategic and innovative partnerships, she is known for challenging the norm rather than moving with it, both at work and in her community. This coupled with her natural intuition and curiosity has led to groundbreaking initiatives in support of improved health and wellness outcomes for the communities she serves.

Dianne works closely with senior government officials—both provincial and across Canada—and a broad sector of the health industry including, pharmaceutical and medical, to foster effective working relationships. Focused on delivering quality results coupled with strong leadership, Dianne is highly engaged as both a director and board chair for various organizations and foundations. Dianne is currently actively serving as a board director for The Royal Alexandra Hospital Foundation, the Women and Children’s Health Research Institute and Edmonton Health Cities.

Dianne strives to make a positive difference in peoples’ lives. With her certification as an Executive Coach through Royal Roads University, she works to inspire and empower individuals to tackle challenges with gusto and to never accept anything less than incredible as an outcome. She looks forward to an engaging dialogue with you.

NEIL FRASER is the President of Medtronic Canada and Regional Vice-President – Canada, Medtronic plc, one of the largest medical technology, services, and solutions companies in the world. He is Co-chair of AdvaMed’s Medtech Virtual Conference, taking place September 8 – October 23, 2020, past chair of Medtech Canada, a former Board Member of Baycrest Health Sciences, and a Member of the Federal Health and Biosciences Economic Strategy Table (ISED/Health). In 2014, he was a Member of the federal Advisory Panel on Healthcare Innovation (the “Naylor report”) and the Ontario Health Innovation Council. He has numerous publications on the topic of healthcare innovation in Canada and is a frequent speaker on the topics of value-based procurement and outcomes-based healthcare.

Helen Trifonopoulos is the Vice-President of Health Policy and Patient Access at Novartis Oncology. She leads a team of professionals responsible for health economics and outcomes research, value and access strategy, government and stakeholder relations, and health systems partnerships.

Helen has over 20 years of experience in the pharmaceutical industry working for Merck and Novartis. She has held roles in commercial, medical education, policy and reimbursement across multiple therapeutic areas and various phases of the product life cycle. Most recently, Helen has had the privilege of working in novel areas like immuno-oncology and cell and gene therapies

Helen’s professional interests lie in exploring ways members of the healthcare ecosystem can work towards enhancing the life sciences in Canada and enabling patient access to innovative therapies while partnering for health system sustainability.

Helen holds a Bachelor of Arts in Political Science from McGill University and an MBA from the John Molson School of Business.

Chad Mitchell is the Assistant Deputy Minister for the Pharmaceutical and Supplementary Benefits Division at Alberta Health. He provides leadership to a high performing team responsible for drug and health benefit programs, Alberta Health Care Insurance plan, interprovincial health agreements and Alberta blood and plasma and the Alberta Organ Donation Registry. With his background as a pharmacist, Chad has worked in community, ambulatory and acute care settings; he has worked for a number of years with Alberta Health, Alberta Health Services, the Alliance for Canadian Health Outcomes Research in Diabetes (ACHORD) through the Institute of Health Economics and the private pharmaceutical sector. Chad is also an adjunct professor with the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta where he received his master’s degree focused in the area of health outcomes research.

Dr. Robert Fraser is the President and CSO of Molecular You, a digital health company delivering molecular-level personalized health insights and action plans. Dr. Fraser has been at the forefront of developing the framework and technologies to bring personalized medicine into healthcare practice. He is the co-founder of The Personalized Medicine Initiative (PMI), GenXys Health Care Systems, Personalized Biomarkers Incorporated, Mesentech Corporation and Novobind. Dr. Fraser has led drug discovery and development projects at Sanofi, Xenon, Neuromed and CDRD and has been involved in raising of more than $37M in funding. He completed his Ph.D. in the molecular mechanisms of endocrinology at the University of Alberta and Harvard Medical School and Post-Doctoral Fellowships at Hospital for Sick Children, Toronto and IGBMC, Strasbourg France.

Joyce is a Partner and British Columbia Leader for Omnia AI, Deloitte Canada’s Artificial Intelligence and Advanced Analytics Practice. Joyce leads a talented team of professionals who provide high quality advice and support to clients on their AI and analytics journey.

Joyce’s career spans 25 years with a unique background in corporate strategy, innovation and exponential technologies to support business leaders make informed and effective decisions leveraging information as an enterprise asset. Joyce has successfully designed and delivered national and international initiatives for private and public sector and has experience in all industry sectors including natural resources, financial services, insurance and telecommunications, with significant experience in healthcare, life sciences and public sector.

Prior to joining Deloitte, Joyce led and delivered one of the largest transformation projects in the world for the National Health Service in the UK, held senior international roles in private sector life sciences and has been a guest lecturer on transformation and health policy at the University of Westminster in London.

Jim Kean leads Journi Infrastructure and Operations which is focused on designing, testing and implementing digitally driven intelligent operations, 3rd party solutions, and human service delivery for Seamless. Current big focus on Telehealth, Remote Patient Monitoring (RPM), Internet of Medical Things (IoMT). Jim’s innovative and entrepreneurial career emphasis has been developing disruptive consumer-oriented fitness, health, and wellness experiences. Prior to joining Cambia in November 2016, Jim was founder and CEO of WellnessFx™, a digital health company focused on providing easy and affordable access to blood-based diagnostics bundled with telehealth consults. He was also founder and president of Sapient Health Network (SHN), which became the consumer-facing business of WebMD. Jim is an avid outdoorsman who enjoys hiking and winter sports with his wife and three children. Contact information: Jim.Kean@cambiahealth.com

Aaron Leibtag cofounded Pentavere in response to a hard-hitting question. Why is it we have all the data we need for financial markets to make money but don’t have the information we need to save lives? This question has never been clearer in light of what we are all going through with COVID 19.

Pentavere uses AI technologies to generate Real World Evidence (RWE) data and lifesaving insights trapped in large repositories of unstructured healthcare data, such as clinical notes, transcription text, lab and diagnostic reports without having to incur the costs, inaccuracies, and time delays of manual processes.

Dr. Matthew Parker, Health Sector Lead at AltaML, leads the health arm of the company. AltaML is working in various areas of Health AI, ranging from care pathway prediction to improving pathology work flows. Previously, Matt was working in commercialization and innovation in Toronto for Sinai Health System. Matt has a PhD in Biochemistry from the University of Victoria and an MBA from the Schulich School of Business with a specialization in Health Industry Management.

Fanny has over 15 years of experience bringing new products and services to the healthcare market. She has extensive experience as a clinician, researcher and business development professional in the area of medical devices, AI and analytics, and digital health assets. She specializes in building meaningful and impactful health system transformations that leverage innovation and achieve fast and sustained growth for entrepreneurs and multinationals in the public and private sector. Fanny is currently a Strategic Health Partners for AI and digital health for Hoffmann-La Roche.

Dr. Russell is Professor of Medicine at University of British Columbia (UBC) and a Principal Investigator in the Centre for Heart Lung Innovation (HLI) at St. Paul’s Hospital where he focuses on septic shock research. Dr. Russell is ranked # 1 in the world in septic shock (http://expertscape.com/ex/septic+shock), vasopressin (http://expertscape.com/ex/vasopressin) and norepinephrine (http://expertscape.com/ex/norepinephrine) according to the independent expert site (expertscape).

In 1982, he founded the Critical Care Medicine (CCM) division at UBC and St. Paul’s, which he has grown to be ranked the # 1 septic shock group in the world. Dr. Russell has three major current themes of research (1) randomized controlled trials in patients with septic shock and now COVID-19, (2) biomarkers of septic shock and COVID-19, and (3) the interaction of diabetes and sepsis/septic shock.

The COVID-19 pandemic led to three CIHR-funded studies of the safety and effectiveness of angiotensin receptor blockers (ARBs) and angiotensin converting enzyme (ACE) inhibitors in COVID-19 in (1) a pan-Canadian observational cohort and (2) a pan-Canadian randomized controlled trial of losartan (an ARB) vs. usual care in adults hospitalized with COVID-19. Dr. Russel is also funded to evaluate the interactions of biological sex with outcomes of COVID-19.

Dr. Russell’s has 280 peer-reviewed journal publications, 45 book chapters (including the chapter on septic shock in Cecil Medicine), 200 research abstracts and 277 invited talks. Dr. Russell has applied this research beyond the lab to improve patient health outcomes by co-founding two spin-off biotech companies: Sirius Genomics Inc. (focused on discovery and development of predictive biomarkers for drugs in sepsis) and Cyon Therapeutics (development of a PCSK9 inhibitor in sepsis). These commercialization efforts generated employment and training opportunities, and raised the profile of Canada’s biotechnology on the world stage.

Dr. Russell’s publications highlight (1) direct high impact on care of critically ill septic patients around the world by publication in high impact journals and (2) most important, illustrate the fundamental strategy of his research career, the successful coupling of expertise in clinical trials and discovery of novel biomarkers that explain mechanisms of therapies in sepsis.

Dr. Scott Halperin is a Professor of Pediatrics and Microbiology and Immunology at Dalhousie University. As Director of CCfV and Nominated Principal Investigator of the Canadian Immunization Research Network, he has played a foundational role in the establishment of these and other Canadian collaborative research networks undertaking evaluative vaccine research that informs public health policy and practice. His research focuses on the diagnosis, treatment, and prevention of pertussis and other vaccine-preventable diseases. He currently serves on the national COVID-19 Immunity Task Force.

Dr. Bettina Hamelin is the President and CEO of Ontario Genomics. Before assuming her current role in August 2017, Bettina served as Vice-President of NSERC’s Research Partnerships Directorate, where she was responsible for a range of programs designed to stimulate increased public/private sector collaboration and technology transfer by connecting the Canadian research enterprise to Canadian and global innovation stakeholders. Bettina has more than 15 years of experience in the biotech and international pharmaceutical industry as well as 10 years of academic experience as a tenured professor at the Faculty of Pharmacy at Université Laval.

Prior to joining NSERC Bettina held a variety of leadership positions at Pfizer Canada, most recently as Canadian Medical Lead, Vaccines, and Head, Strategic Research Partnerships, Western Canada. She is passionate about bringing together unlikely partners to attract and leverage funds from diverse sources. She is known for pioneering novel public-private partnership models, and breaking down barriers between federal, provincial and private sector stakeholders.

Early roots in biology and chemistry (Vordiplom, Universität Kaiserslautern, Germany) have led Bettina to complete a B.Sc. in pharmacy and a Doctor of Pharmacy, both from the University of Kentucky, U.S. and an EMBA in Healthcare from the University of British Columbia, Canada.

James is a co-founder and Chief Scientific Officer at Helix. Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by our proprietary Exome+ ® assay, Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information.

Prior to Helix, James was a faculty member at Duke University where he focused on
translational genomics and machine learning methodologies for EMRs. James has explored research topics in population genetics, Mendelian genomics, and computational psychiatry. James holds an M.D. and Ph.D. from the Baylor College of Medicine. He also received a B.S. and M.S. in Chemical Engineering from Stanford University.

Donna Wilson is the Executive Vice President at the Provincial Health Services Authority in British Columbia. She also holds executive accountability for Diagnostic and Treatment Services across British Columbia. These services include the Provincial Laboratory Medicine Services, Lower Mainland diagnostic imaging and Lower Mainland in-hospital pharmacy services. Prior to joining the health sector in BC, Donna was Senior Vice President, People, Community and Strategy at LifeLabs Canada’s largest private laboratory. Donna has held various executive roles in financial services, professional sport events and insurance services since 2001. A highlight of her career was delivering the 2010 Olympics in Vancouver and Whistler as the Executive Vice President, Workforce & Sustainability at the Vancouver Olympic Organizing Committee. Donna holds a Bachelor of Arts in Psychology from Simon Fraser University and an Executive Management Certificate from Queens University, and is a Chartered Director (McMaster University).

Dr. Pieter R. Cullis, PhD is a professor in the Department of Biochemistry and Molecular Biology at the University of British Columbia, co-founder and co-chair of the Personalized Medicine Initiative, and director of the NanoMedicines Research Group at UBC. He has co-founded numerous companies and organisations, including Lipex Biomembranes Inc., Arbutus Biopharma, Northern Lipids Inc. (now Evonik), Acuitas Therapeutics and Precision NanoSystems, and the Centre for Drug Research and Development, where he was Founding Scientific Director from 2004 – 2010.

Cullis has contributed to fundamental advances in the generation, loading and targeting of lipid nanoparticle (LNP) systems for intravenous delivery of small molecule and macromolecular drugs. This work has contributed to three approved LNP products for the treatment of cancer and its complications and a fourth gene therapy drug to treat an hereditary condition that recently completed a most successful Phase 3 trial. He also works to influence the health care system to introduce personalized medicine based on molecular makeup of the individual and their disease.

Cullis has received numerous awards. He was elected as a Fellow of the Royal Society of Canada in 2004 and received the Journal of Drug Targeting’s Lifetime Achievement Award in 2016.

Robin Gould-Soil is a recognized authority on privacy and data protection. She has been at the forefront of this burgeoning field for two decades, and has unique expertise resulting from her multi-sector experience across the corporate and public spheres, including executive roles at TD Bank Group, HSBC Canada, the Office of the Privacy Commissioner of Canada (OPC) and the University Health Network (UHN). Robin has spearheaded award-winning privacy initiatives, successfully engaged with a broad range of constituencies and peers, and built effective data protection and governance frameworks for large, global organizations.

David Helliwell is a software entrepreneur who has spent much of his career building mission-driven companies in the healthcare and cleantech industries. Prior to co-founding Thrive Health in 2017, David co-founded Pulse Energy in 2006, which evolved into the world’s leading energy intelligence software company at the time of its sale in 2014. Thrive Health’s
mission is to make healthcare work better for everyone with innovative patient engagement & clinical decision support tools. Thrive Health is based in Vancouver and has helped over 10 million Canadians through their healthcare journeys.

David is a mentor and angel investor with international healthtech start-ups through the Creative Destruction Lab and has served two terms on the advisory board for the National Research Council’s Industrial Research Assistance Program (IRAP).

Wendy is a career executive with more than 20 years of Global Finance, Operations and Compliance experience in the healthcare and technology sectors. She is a leader with strong business acumen and a history of enabling business growth through the development of global strategic partnerships, new business development initiatives, transformation projects, and the integration of new businesses and/or business models. Has a proven track record of developing, executing, and delivering solid business plans and growing shareholder value.

She has held leadership positions at Johnson & Johnson, the Heart & Stroke Foundation, LIFESCAN Canada and Lexmark International.

She is a certified Data and Privacy Professional and has managed Privacy and Healthcare Compliance programs both here in Canada and in the US for the better part of her career. Working both in the corporate environment and in private practice, she has taken the lead on compliance, regulatory and privacy issues for the last 20 years.

Wendy has a BA from the University of Western Ontario, an MBA from Queen’s University and a Certificate in Strategic Leadership from the Sauder School of Executive Education, UBC.

In addition, Wendy serves on the Board of Directors of The Centre for Drug Research and Development, Chair’s CDRD’s Finance & Audit Committee and also serves on the Vancouver Board of Trade Women in Leadership Advisory Committee. 

Certifications:

• Certificate in Intermediate French, Louvain-la-Neuve, Belgium
• Registered Holistic Nutritionist – Candidate, Canadian School of Natural Nutrition – Ongoing
• Certified Canadian Privacy Professional, IAPP, CIPP/C (since 2012)
• Certificate in Strategic Leadership, UBC Sauder School of Business – Executive Education
• Leadership Development Program, Niagara Institute
• Executive Leadership Program, Harvard University, Boston, MA
• Canadian Securities Course

Patricia Kosseim brings to the IPC significant experience and a wealth of knowledge in the areas of privacy and access law, having worked in public, private and health sectors, and across various jurisdictions.

Prior to joining the IPC, Patricia was counsel in Osler’s Privacy and Data Management Group where she provided strategic advice to clients on matters of privacy, data governance and access law. She also led a number of thought leadership initiatives as national co-leader of Osler’s AccessPrivacy knowledge platform.

Patricia served for more than a decade as senior general counsel and director general at the Office of the Privacy Commissioner of Canada in Ottawa. During that period, she was responsible for advancing a number of major cases before the federal courts and the Supreme Court of Canada; advising on critical privacy investigations; appearing before parliamentary committees on significant legislative bills; developing national and international policies; leading a national research funding program; and, overseeing a technology analysis team and laboratory.

Patricia has also held executive positions at Genome Canada and the Canadian Institutes of Health Research, where she developed and led national strategies for addressing legal, ethical, and social aspects of health research and genomics technologies. She began her career in Montreal practicing in the areas of health law, civil litigation, human rights, privacy, and labor and employment with a leading national law firm.

Patricia has published and spoken extensively on matters of privacy law, health law, and ethics. She has taught part-time at the University of Ottawa Faculty of Law and has held many professional appointments and board memberships, including as member of the Board of Governors of the Ottawa Hospital; chair of the Board of Directors of the Ottawa Hospital Research Institute; vice-chair of the Research Integrity Committee of les Fonds de recherche du Quebec; member of the National DNA Databank Advisory Committee; and member of various expert working groups of the Organization for Economic Co-operation and Development.

Patricia obtained her business and law degrees from McGill University in Montreal, and a Master’s Degree in Medical Law and Ethics from King’s College, University of London.

Patricia is a member of the Law Society of Ontario, as well as the Barreau du Quebec. She is fluently bilingual in both official languages.

When she is not in the office — either physically or virtually — Patricia enjoys all-season, outdoor activities with her family, and their dog Rocky.

Pamela Snively joined TELUS as Chief Data and Trust Officer in October, 2015. She leads the team responsible for data and privacy governance at TELUS. Pamela also serves TELUS’ commitment to integrity through her leadership of a variety of initiatives, including the Anti-bribery & Corruption and Competition Law programs.

Prior to joining TELUS, Pamela managed the consulting arm of Osler’s privacy and data management practices, AccessPrivacy by Osler. As a lawyer and consultant, she provided a broad range of privacy, risk-management and compliance advice in the private, public and health sectors. She assisted organizations in implementing enterprise risk-management programs; advising on privacy and outsourcing governance and accountability programs; designing and implementing records-management programs; drafting policies, procedures and training materials; managing data breaches and other regulatory investigations; and conducting privacy impact or risk assessments.

Pamela formerly held Chief Privacy and Risk Officer roles in large business process outsourcing companies in Canada.

Shawn Surber has spent more than 20 years in Healthcare Information Technology as a Trainer, System Administrator, Security Architect, and Leader. With the explosion in quantity and value of electronic patient data and the corresponding increase in cyberthreats, he’s taken an exclusive focus on information security for the last dozen years. He has architected, deployed, and managed security solutions for some of the largest healthcare organizations in the United States over the course of his career. Now, he has taken his passion for optimizing and securing healthcare IT organizations to Tanium, an organization dedicated to securing the largest and most important networks in the world.

Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.

Dr. Pieter R. Cullis, PhD is a professor in the Department of Biochemistry and Molecular Biology at the University of British Columbia, co-founder and co-chair of the Personalized Medicine Initiative, and director of the NanoMedicines Research Group at UBC. He has co-founded numerous companies and organisations, including Lipex Biomembranes Inc., Arbutus Biopharma, Northern Lipids Inc. (now Evonik), Acuitas Therapeutics and Precision NanoSystems, and the Centre for Drug Research and Development, where he was Founding Scientific Director from 2004 – 2010.

Cullis has contributed to fundamental advances in the generation, loading and targeting of lipid nanoparticle (LNP) systems for intravenous delivery of small molecule and macromolecular drugs. This work has contributed to three approved LNP products for the treatment of cancer and its complications and a fourth gene therapy drug to treat an hereditary condition that recently completed a most successful Phase 3 trial. He also works to influence the health care system to introduce personalized medicine based on molecular makeup of the individual and their disease.

Cullis has received numerous awards. He was elected as a Fellow of the Royal Society of Canada in 2004 and received the Journal of Drug Targeting’s Lifetime Achievement Award in 2016.

John is an Executive-in-Residence at the Harvard Medical School Executive Education. He is a former senior vice president of Population Health, at Cerner Corporation. Previously he was chief executive officer of Siemens Heath Services. Prior to Siemens, John was chief information officer at Partners HealthCare.

John was the founding chair of the College of Healthcare Information Management Executives (CHIME) and the past-president of the Healthcare Information and Management Systems Society (HIMSS). He is the former Chair of the Global Agenda Council on Digital Health, World Economic Forum. He is former Senior Advisor to the Office of the National Coordinator for Health Information Technology.

John serves on the boards of the Scottsdale Institute, PatientPing, National Committee for Quality Assurance, the American Telemedicine Association, Wellsheet, eHealth Initiative and Relatient.

John has received numerous industry awards including the John P. Glaser Innovation Award (established by the School of Biomedical Informatics, UTHealth), William B. Stead Thought Leadership Award (American Medical Informatics Association) and the Lifetime Achievement Award (CHIME).

John received his Ph.D. from the University of Minnesota. He has written over 200 articles and three books on the strategic application of IT in health care, including the most widely used textbook in the field. He is on the faculty of the Wharton School at the University of Pennsylvania, the UTHealth School of Biomedical Informatics and the Harvard School of Public Health.

Dr. Kendall Ho’s academic and research interests fall into the domain of technology-enabled knowledge translation (TEKT) – the use of information technologies to accelerate the incorporation of the latest health evidence into routine practice. Specific directions within TEKT include telehealth, information and communication technologies (ICT) and patient safety, ICT and public engagement, and evidence-based policy translation in eHealth.

With more than 20 years of international experience in both the academic and private sectors, Dr. Catalina Lopez-Correa’s deep understanding of genomics and innovation has inspired leaders in science and industry to collaborate toward solving some of the world’s greatest challenges.

Dr. Lopez-Correa is the Executive Director of the Canadian COVID Genomics Network (CanCOGeN) at Genome Canada, where she is leading a pan Canadian collaborative effort to sequence viral and human genomes to help inform public health and policy decision. Before joining Genome Canada, Dr. Lopez Correa was Chief Operating Officer at Ruta N Medellin. In this capacity, she led the operations of a world class innovation hub that uses cutting edge technologies to solve the city’s most pressing social and economic challenges. Prior to Ruta N, Dr. Lopez-Correa was the CSO and Vice-President Sectors at Genome British Columbia (2016-2019) and CSO and Vice-president Scientific Affairs at Genome Quebec (2008-2015), where she was instrumental in developing competitive teams for national and provincial research and innovation initiatives raising the profile of Canadian genomics on the global stage.

Before becoming one of Canada’s leading advocates for genomics research and translation, and an international leader in using innovation to solve world challenges, Dr. Lopez-Correa held senior research positions with pharmaceutical giant Eli Lilly and the renowned deCODE genetics lab in Iceland. As part of her commitment to international development, Dr. Lopez-Correa has championed several initiatives aimed at demonstrating the impact of genomics and innovation in developing countries, including a book on Genomics in Emerging Economies, white paper with the World Economic Forum and several articles. Since 2002 she has served as evaluator for large multinational projects funded by the European Commission and has been recognized with several awards nationally and internationally.

Dr. Lopez-Correa holds a Medical degree from the UPB in Colombia, a Master’s degree in Human Genetics from Paris V University in France, a PhD in Medical Sciences from the KULeuven in Belgium, and a mini MBA from McGill University in Canada.

Awards:
In 2017 she received the Canadian Senate 150th Anniversary Medal. In 2013 she was recognized by National Order of Merit Award in the Rank of Officer, appointed by the Honorable President of the Republic of Colombia. This honorable distinction is conferred to Dr. Lopez-Correa for her outstanding professional and academic career and the scientific contributions in the field of Genomics in Canada. In 2012 she was recognized as one of the 100 Colombians living abroad that have been highly successful on their professional career.

Sue is the CEO of Canada’s Digital Technology Supercluster – driving the development of digital technology platforms and products that will transform businesses and industries while making Canada a world leader in digital technology. The Digital Technology Supercluster brings together organizations of all sizes, from industry, academia, the private and the public sector, to work together on solving some of the most significant economic and social issues through the development and implementation of world leading digital technologies. The Supercluster is leveraging Canada’s expertise in data analytics, genomics, quantum computing, mixed and augmented reality, the Internet of Things and AR and VR to deliver technologies in data commons, digital twins and all aspects of precision health while creating jobs and growing Canada’s international competitiveness. Over 300 organizations are working with the Supercluster from diverse sectors including manufacturing, mining, healthcare, agriculture, research, forestry, aviation, software development, telecom and more.

Prior to joining the Supercluster Sue was the Managing Partner of one of Canada’s leading law firms, the CEO of Canada’s largest chain of independent retail pharmacies and most recently the CEO of Canada’s largest diagnostic lab. In each of these roles Sue mobilized diverse teams to drive business growth, implement large-scale organizational change and develop and implement transformational technologies.

Sue and her husband Brad are the proud parents of three daughters and when not transforming organizations, Sue and her family can be found in remote areas of BC’s wilderness, exploring all that BC has to offer. Sue has been recognized for community and business leadership with awards including: Honorary Doctorate of Technology (BCIT), UBC Faculty of Law Distinguished Alumni Award, University of Victoria Distinguished Entrepreneur, YWCA Woman of Distinction, Queen’s Counsel, Hall of Fame for Canada’s Top 100 Most Powerful Women, and the Influential Women in Business Lifetime Achievement Award.

Howard Waldner is the past President and Chief Executive Officer of Vancouver Island Health Authority, serving in this role from 2004 until 2013. He is curently CEO of Caledonia Solutions, a strategic consulting company he founded in 2013.

He is a visionary and innovative leader with over 30 years of experience of managing health sysytems in both Canada and the U.K. He has a keen interest in system innovation, transformation and performance improvement. He is also passionate in the area of health facility planning, design and procurement and has led the development of number of large and successful hospital projects using both traditional and alternate funding approaches. He received the Canadian College of Health Leaders National Award for Innovation in Health in 2013.

He is a certified member of the Institute of Corporate Directors, and currently serves as an Independent Board Director of Strata-Health Solutions, a successful Calgary based Health IT company, and is a partner with Prioritize Software, a Vancouver based strategic solutions company. He also serves as a volunteer member of the Telus (Victoria) Community Board and has served on a number of “non-profit” Boards, including the Canadian Institute for Health Information, the BC Academic Health Council, (which he chaired for 5 years), the United Way Campaign Cabinet, Carewest, VRRI, and the Greater Victoria Coalition to end Homelessness.

Prior to joining VIHA in 2004, he was the Deputy Chief Executive and Executive Vice President and Chief Operating Officer for the former Calgary Health Region from 1999 until 2004. Before moving to Calgary in 1999, he held a number of senior leadership roles within the Scottish National Health Service, most recently as the Chief Executive of Dundee University Teaching Hospitals NHS Trust.

He received his Executive MBA from the University of Glasgow, Scotland, and is a Certified member of the Canadian College of Health Leaders and a Fellow of the United Kingdom Institute of Health Care Managers.

He is Adjunct Professor in the Faculty of Medicine of the University of British Columbia, and teaches on a number of executive leadership and masters programs in the School of Public and Population Health.

Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.